Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Other Operating Expenses: 2014-2021

Historic Other Operating Expenses for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Mar 2021 value amounting to -$53,000.

  • Avadel Pharmaceuticals' Other Operating Expenses fell 101.88% to -$53,000 in Q1 2021 from the same period last year, while for Mar 2021 it was -$39.7 million, marking a year-over-year decrease of 339.20%. This contributed to the annual value of -$53,000 for FY2021, which is 100.12% down from last year.
  • Avadel Pharmaceuticals' Other Operating Expenses amounted to -$53,000 in Q1 2021, which was up 76.55% from -$226,000 recorded in Q3 2020.
  • In the past 5 years, Avadel Pharmaceuticals' Other Operating Expenses registered a high of $72.8 million during Q4 2018, and its lowest value of -$42.2 million during Q2 2020.
  • Moreover, its 3-year median value for Other Operating Expenses was $3.1 million (2019), whereas its average is -$2.7 million.
  • In the last 5 years, Avadel Pharmaceuticals' Other Operating Expenses skyrocketed by 1,251.23% in 2018 and then tumbled by 1,324.93% in 2020.
  • Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Other Operating Expenses stood at $5.4 million in 2017, then spiked by 1,251.23% to $72.8 million in 2018, then plummeted by 90.82% to $6.7 million in 2019, then tumbled by 106.18% to -$226,000 in 2020, then tumbled by 101.88% to -$53,000 in 2021.
  • Its Other Operating Expenses stands at -$53,000 for Q1 2021, versus -$226,000 for Q3 2020 and -$42.2 million for Q2 2020.